---
title: "Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284762263.md"
description: "Barinthus Biotherapeutics plc, headquartered in Germantown, Md., released its financial report for the quarter ending March 31, 2026. Operating under the ticker symbol BRNS on NASDAQ, the company, specializing in immunology and inflammation, emphasized their aim to create treatments fostering immune tolerance and potentially curative impacts. The announcement included an update on the corporate progress of Barinthus Bio."
datetime: "2026-04-30T11:31:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284762263.md)
  - [en](https://longbridge.com/en/news/284762263.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284762263.md)
---

# Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments

Barinthus Biotherapeutics plc, headquartered in Germantown, Md., released its financial report for the quarter ending March 31, 2026. Operating under the ticker symbol BRNS on NASDAQ, the company, specializing in immunology and inflammation, emphasized their aim to create treatments fostering immune tolerance and potentially curative impacts. The announcement included an update on the corporate progress of Barinthus Bio.

### Related Stocks

- [BRNS.US](https://longbridge.com/en/quote/BRNS.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)